Zydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 ...

PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis-- ...

Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral ...

Ancient viral DNA embedded in the human genome has been linked to the genetic risks of certain neurodegenerative diseases, ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

A WOMAN from Salisbury had her head shaved to raise money for charity after being diagnosed with MS. Hannah Schmidt, 35, is a mum of three boys and the family lives in Salisbury. In December 2020, she ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) with generous support from EMD Serono's Embracing Caregivers initiative, announced today the launch of a new website designed to support the ...